Literature DB >> 17406720

Ruthenium half-sandwich complexes as protein kinase inhibitors: derivatization of the pyridocarbazole pharmacophore ligand.

Nicholas Pagano1, Jasna Maksimoska, Howard Bregman, Douglas S Williams, Richard D Webster, Feng Xue, Eric Meggers.   

Abstract

A general route to ruthenium pyridocarbazole half-sandwich complexes is presented and applied to the synthesis of sixteen new compounds, many of which have modulated protein kinase inhibition properties. For example, the incorporation of a fluorine into the pyridine moiety increases the binding affinity for glycogen synthase kinase 3 by almost one order of magnitude. These data are supplemented with cyclic voltammetry experiments and a protein co-crystallographic study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406720     DOI: 10.1039/b700433h

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  16 in total

1.  Similar biological activities of two isostructural ruthenium and osmium complexes.

Authors:  Jasna Maksimoska; Douglas S Williams; G Ekin Atilla-Gokcumen; Keiran S M Smalley; Patrick J Carroll; Richard D Webster; Panagis Filippakopoulos; Stefan Knapp; Meenhard Herlyn; Eric Meggers
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

2.  Organometallic Pyridylnaphthalimide Complexes as Protein Kinase Inhibitors.

Authors:  Sebastian Blanck; Thomas Cruchter; Adina Vultur; Radostan Riedel; Klaus Harms; Meenhard Herlyn; Eric Meggers
Journal:  Organometallics       Date:  2011-07-18       Impact factor: 3.876

3.  Automated Multistep Continuous Flow Synthesis of 2-(1H-Indol-3-yl)thiazole Derivatives.

Authors:  Nicholas Pagano; Marintha L Heil; Nicholas D P Cosford
Journal:  Synthesis (Stuttg)       Date:  2012       Impact factor: 3.157

4.  Bioactive cyclometalated phthalimides: design, synthesis and kinase inhibition.

Authors:  Sebastian Blanck; Yann Geisselbrecht; Katja Kräling; Stephen Middel; Thomas Mietke; Klaus Harms; Lars-Oliver Essen; Eric Meggers
Journal:  Dalton Trans       Date:  2012-06-26       Impact factor: 4.390

5.  An organometallic inhibitor for the human repair enzyme 7,8-dihydro-8-oxoguanosine triphosphatase.

Authors:  Manuel Streib; Katja Kräling; Kristin Richter; Xiulan Xie; Holger Steuber; Eric Meggers
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-20       Impact factor: 15.336

6.  From imide to lactam metallo-pyridocarbazoles: distinct scaffolds for the design of selective protein kinase inhibitors.

Authors:  Nicholas Pagano; Eric Y Wong; Tom Breiding; Haidong Liu; Alexander Wilbuer; Howard Bregman; Qi Shen; Scott L Diamond; Eric Meggers
Journal:  J Org Chem       Date:  2009-12-04       Impact factor: 4.354

7.  A general solution for unstable boronic acids: slow-release cross-coupling from air-stable MIDA boronates.

Authors:  David M Knapp; Eric P Gillis; Martin D Burke
Journal:  J Am Chem Soc       Date:  2009-05-27       Impact factor: 15.419

8.  The crystal structure of BRAF in complex with an organoruthenium inhibitor reveals a mechanism for inhibition of an active form of BRAF kinase.

Authors:  Peng Xie; Craig Streu; Jie Qin; Howard Bregman; Nicholas Pagano; Eric Meggers; Ronen Marmorstein
Journal:  Biochemistry       Date:  2009-06-16       Impact factor: 3.162

9.  Toward the development of a potent and selective organoruthenium mammalian sterile 20 kinase inhibitor.

Authors:  Ruchi Anand; Jasna Maksimoska; Nicholas Pagano; Eric Y Wong; Phyllis A Gimotty; Scott L Diamond; Eric Meggers; Ronen Marmorstein
Journal:  J Med Chem       Date:  2009-03-26       Impact factor: 7.446

10.  Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.

Authors:  Alex N Bullock; Santina Russo; Ann Amos; Nicholas Pagano; Howard Bregman; Judit E Debreczeni; Wen Hwa Lee; Frank von Delft; Eric Meggers; Stefan Knapp
Journal:  PLoS One       Date:  2009-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.